Results 131 to 140 of about 12,689 (172)

Effects of semaglutide, a GLP-1 receptor agonist, on food preferences in Japanese subjects with type 2 diabetes and visceral fat accumulation. [PDF]

open access: yesEndocr J
Hara T   +10 more
europepmc   +1 more source

Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans. [PDF]

open access: yesCell Rep Med
Langer HT   +21 more
europepmc   +1 more source

Increased semaphorin, neuropilin, and plexin expression plays a role in recovery after traumatic brain injury. [PDF]

open access: yesMetab Brain Dis
Okan A   +5 more
europepmc   +1 more source

Correction: Real-World 6-Month Treatment Outcomes of Faricimab in Turkey: The FARTURK Study. [PDF]

open access: yesOphthalmol Ther
Çakır A   +48 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy